Fagotti, Anna
 Distribuzione geografica
Continente #
NA - Nord America 8.408
EU - Europa 7.355
AS - Asia 2.784
AF - Africa 63
SA - Sud America 38
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 11
Totale 18.679
Nazione #
US - Stati Uniti d'America 8.352
DE - Germania 1.660
SE - Svezia 1.649
IT - Italia 1.346
CN - Cina 1.103
SG - Singapore 897
IE - Irlanda 598
UA - Ucraina 499
ID - Indonesia 375
FR - Francia 371
PL - Polonia 355
GB - Regno Unito 215
RU - Federazione Russa 207
FI - Finlandia 173
IN - India 166
TR - Turchia 77
BE - Belgio 61
CI - Costa d'Avorio 47
NL - Olanda 47
CZ - Repubblica Ceca 40
CA - Canada 38
IR - Iran 35
JP - Giappone 32
HK - Hong Kong 29
ES - Italia 20
AT - Austria 19
CH - Svizzera 18
AU - Australia 17
RO - Romania 15
BR - Brasile 14
BZ - Belize 11
KR - Corea 11
PH - Filippine 11
GR - Grecia 10
EU - Europa 9
HR - Croazia 9
CL - Cile 8
LT - Lituania 8
OM - Oman 7
EG - Egitto 6
MX - Messico 6
PT - Portogallo 6
SA - Arabia Saudita 6
VN - Vietnam 6
HU - Ungheria 5
IL - Israele 5
MD - Moldavia 5
MY - Malesia 5
AR - Argentina 4
DK - Danimarca 4
PE - Perù 4
PK - Pakistan 4
BD - Bangladesh 3
BG - Bulgaria 3
EC - Ecuador 3
EE - Estonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
GF - Guiana Francese 2
LA - Repubblica Popolare Democratica del Laos 2
LI - Liechtenstein 2
LK - Sri Lanka 2
MA - Marocco 2
MK - Macedonia 2
NG - Nigeria 2
ZA - Sudafrica 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
ET - Etiopia 1
IQ - Iraq 1
MT - Malta 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
TW - Taiwan 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 18.679
Città #
Chandler 2.049
Ashburn 753
Singapore 714
Dublin 592
San Mateo 402
Jakarta 366
Warsaw 339
Jacksonville 294
Wilmington 286
Ann Arbor 256
Rome 246
New York 234
Boston 228
Nanjing 210
Milan 192
Princeton 184
Woodbridge 176
Moscow 165
Houston 163
Beijing 160
Fairfield 158
Marseille 156
Dearborn 147
Cattolica 123
Nürnberg 105
Redwood City 99
Seattle 99
Lawrence 97
Boardman 82
Los Angeles 66
Nanchang 66
Munich 61
Bremen 56
Brussels 55
Mountain View 54
Hangzhou 52
Helsinki 51
Izmir 49
Abidjan 47
Kunming 47
Norwalk 45
Cambridge 44
Leawood 41
Zhengzhou 38
Fuzhou 35
Hebei 34
Shenyang 31
Changsha 30
Redmond 30
Augusta 29
Oggiono 28
University Park 28
Busto Arsizio 27
Detroit 27
Pune 27
Amsterdam 26
Chicago 26
Lancaster 25
Guangzhou 24
Washington 23
Andover 21
Shanghai 21
Jiaxing 20
Olomouc 20
Tianjin 20
Falls Church 19
London 19
Naples 18
Toronto 18
Hefei 17
Lappeenranta 17
Paris 17
Hong Kong 16
Vienna 16
Edinburgh 15
Fremont 15
San Francisco 15
Ardabil 14
Bari 14
Salò 14
San Jose 14
Brno 13
Frankfurt am Main 13
Genazzano 12
Jinan 12
Belize City 11
Buffalo 11
Clearwater 11
Santa Clara 11
Orange 10
Tokyo 10
Changchun 9
Kraków 9
Lanzhou 9
Wuhan 9
Chengdu 8
Kish 8
Madrid 8
San Diego 8
Zagreb 8
Totale 10.847
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 796
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 310
Laparoendoscopic Single-Site Surgery (LESS) for Treatment of Benign Adnexal Disease: Single-Center Experience Over 3-Years 303
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 244
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 235
Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials. 234
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 166
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 165
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 163
Delaying surgery for patients with a previous SARS-CoV-2 infection 149
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 147
Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery 145
Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator: is it a bias for frozen section analysis? Case-control study 144
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 135
Urologic surgery in gynecologic oncology: a large single-institution experience 135
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 130
Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes 129
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 129
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 127
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 127
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. 123
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 122
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 115
Importance of a specialized pathologist for the examination of frozen sections of adnexal masses. 113
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 113
Teaching and training in laparoscopic surgery: experience of Catholic Laparoscopy Advanced Surgery School in the basic gynecological surgery 110
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 110
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 107
Sexual and reproductive outcomes in early stage cervical cancer patients after excisional cone as a fertility-sparing surgery: An italian experience 106
Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery 104
Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience 103
Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a propective study 101
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study 100
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data 99
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer 98
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 90
Excisional cone as fertility-sparing treatment in early-stage cervical cancer. 88
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 87
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial 86
Role of different approaches to the abdominal retroperitoneum for aortic lymphadenectomy in patients with gynecological cancers 86
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): A feasibility study 86
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome 84
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 84
Targeting the hallmarks of ovarian cancer: The big picture 80
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings 80
TELELAP ALF-X Robotic-assisted Laparoscopic Hysterectomy: Feasibility and Perioperative Outcomes 79
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 79
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 79
Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience 77
Telelap ALF-X vs Standard Laparoscopy for the Treatment of Early-Stage Endometrial Cancer: A Single-Institution Retrospective Cohort Study 77
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 77
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer 76
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 76
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 76
Perioperative outcomes of laparoendoscopic single-site surgery (LESS) versus conventional laparoscopy for adnexal disease: a case--control study 75
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 75
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 74
Resectability and Vascular Management of Retroperitoneal Gynecological Malignancies: A Large Single-institution Case-Series 74
Molecular profile of brca-negative long survivor high grade serous ovarian cancer patients using a somatic multigene panel 74
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer 73
Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back 73
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature 73
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments 73
Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications 72
The new robotic TELELAP ALF-X in gynecological surgery: single-center experience 72
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 72
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications 72
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study 71
Systematic pelvic and aortic lymphadenectomy in advanced ovarian cancer patients at the time of interval debulking surgery: a double-institution case-control study 71
Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients 71
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 70
Robotic treatment of colorectal endometriosis: technique, feasibility and short-term results 70
Role of Intraoperative Ultrasound to Extend the Application of Minimally Invasive Surgery for Treatment of Recurrent Gynecologic Cancer 70
Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach 70
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: Proof of a concept 69
Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study 69
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 69
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 69
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 68
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 68
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 68
BRCA testing delay during the COVID-19 pandemic: How to act? 68
Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience 68
Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer. 66
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 66
The role of liquid based cytology and ancillary techniques in the peritoneal washing analysis: Our institutional experience 66
Neoadjuvant chemoradiation followed by radical hysterectomy in FIGO Stage IIIB cervical cancer: feasibility, complications, and clinical outcome. 65
Is There a Role for Tertiary (TCR) and Quaternary (QCR) Cytoreduction in Recurrent Ovarian Cancer? 65
Feasibility and Surgical Outcome in Obese Versus Nonobese Patients Undergoing Laparoendoscopic Single-site Hysterectomy: A Multicenter Case-control Study 64
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 64
Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survival 63
Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer 63
Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis 63
Peritoneal Hpv-Dna Test In Cervical Cancer (Pioneer Study): A Proof Of Concept 63
Sentinel lymph node detection in endometrial cancer with indocyanine green: laparoscopic versus robotic approach 63
[Prevention of postoperative abdominal adhesions in gynecological surgery. Consensus paper of an Italian gynecologists' task force on adhesions] 62
Additional molecular and clinical evidence open the way to definitive IARC classification of the BRCA1 c.5332G > A (p.Asp1778Asn) variant 62
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 62
Prognostic Significance of Ultrasound Characteristics and Body Mass Index in Patients with Apparent Early-Stage Cervical Cancer: A Single-Center, Retrospective, Cohort Study 61
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case Matched Control Study 61
Totale 10.424
Categoria #
all - tutte 100.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.472 0 0 0 0 123 214 261 125 213 156 227 153
2020/20211.861 129 161 227 142 232 66 198 50 192 115 296 53
2021/20222.580 170 118 30 257 99 67 96 433 122 153 445 590
2022/20235.649 750 716 452 767 381 731 275 396 692 98 244 147
2023/20243.284 118 886 101 284 101 370 225 124 74 192 353 456
2024/20251.526 155 132 526 236 477 0 0 0 0 0 0 0
Totale 19.636